Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

In patients older than 40 years, the type 2 diabetes drug class showed increased benefits over DPP-4 inhibitors at reducing ...

"These mechanisms collectively may reduce the risk of cognitive decline, particularly in diabetic patients, and warrant ...

Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

Taking SGLT-2 inhibitors was associated with a 35% lower risk of developing dementia compared with taking another common diabetes drug with a different mechanism. Although the authors call for ...

According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...

A study reveals SGLT-2 inhibitors significantly reduce dementia risk in type 2 diabetes patients, with effects strengthening ...

Like other drugs for heart failure, SGLT2 inhibitors were originally developed to lower blood sugar levels in patients with diabetes. But this drug soon found its way into the heart of clinics that ...

A drug normally used to treat diabetes can significantly reduce your risk of developing dementia, new research has revealed.

As well as confirming the result, more research is needed ‘to explore the underlying mechanisms of any neuroprotective effects of SGLT2 inhibitors’, the team concluded. SGLT2 inhibitors are also ...